HIV and cardiovascular risk factors

Area of Science:

• Cardiology
• Infectious Diseases
• Metabolic Disorders

Background:

• Growing concern exists regarding metabolic complications in HIV patients on Highly Active Antiretroviral Therapy (HAART).
• Traditional cardiovascular risk factors (hypertension, hyperlipidemia, diabetes, visceral fat) are prevalent in HIV patients.
• Non-modifiable risk factors (male sex, age > 40, family history) and lifestyle factors (smoking, sedentary behavior) also contribute to coronary artery disease (CAD) risk.

Purpose of the Study:

• To investigate the potential link between HIV, HAART, and accelerated coronary artery disease (CAD).
• To assess the impact of metabolic complications and traditional risk factors on cardiovascular health in HIV patients.

Main Methods:

• Review of traditional cardiovascular risk factors in HIV patients on HAART.
• Analysis of existing short-term studies and cross-sectional data on cardiovascular complications in HIV patients.
• Comparison of cardiovascular risk in HIV-positive individuals with age-matched HIV-negative populations.

Main Results:

• Traditional and non-traditional cardiovascular risk factors are common in HIV patients on HAART.
• Short-term studies do not currently indicate an increased risk of cardiovascular complications or cardiac death in this population.
• HIV patients face cardiovascular risks comparable to HIV-negative individuals with similar risk profiles.

Conclusions:

• While long-term data is pending, identifying and managing modifiable cardiovascular risk factors is essential for all HIV patients.
• HAART may accentuate existing risk factors, but these complications also occur in younger patients without other risk factors.
• Effective management of modifiable risk factors is pertinent for mitigating potential cardiovascular disease in HIV patients.